Buscar
Congreso SOLACI
HomeCoronary diseaseAcute coronary syndromes

Acute coronary syndromes

Ver Categoría

Acute coronary syndromes

ACC 2024 | REDUCE AMI: Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction

Most clinical trials have shown benefits of beta blockers after acute myocardial infraction, including patients with extensive...
solaci -
Ver más
Acute coronary syndromes

ACC 2024 | DanGer-Shock Trial

Cardiogenic shock will develop in approximately 10% of patients with ST elevated acute MI (STEMI), and unfortunately,...
solaci -
Ver más
Acute coronary syndromes

Virtual Flow Reserve (VFR): Virtual Physiological Test with OCT

Assessing intermediate coronary lesions with intracoronary physiology tests such as fractional flow reserve (FFR) or other non-hyperemic...
solaci -
Ver más
Acute coronary syndromes

Network Meta-Analysis of Complementary Imaging (IVUS/OCT + Conventional Angiography) for Coronary Stenting

Complementary imaging allows for the identification of numerous scenarios not visible with conventional angiography (ICA), both for...
solaci -
Ver más
Acute coronary syndromes

KODRA Registry: Distal Radial Access as First Choice in Coronary Procedures

The first experiences with distal radial access (DRA) have revealed significant benefits compared against the transradial approach...
solaci -
Ver más
Acute coronary syndromes

Preparation Before Elective Coronary Angiography: Is Prolonged Fasting the Only Option?

When scheduling a coronary angiography, patients are usually instructed to fast for at least 8 hours (no oral...
solaci -
Ver más
Acute coronary syndromes

Clopidogrel Monotherapy Beyond 12 months: Long Term Analysis of the STOPDAPT-2

Short dual antiplatelet therapy (DAPT) has shown benefits in patients receiving drug eluting stents (DES), reducing bleeding...
solaci -
Ver más
Acute coronary syndromes

Optimal Duration of DAPT with Oral Anticoagulation After PCI?: 1 Month vs. 3 Months

While the benefits of dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 inhibitor are recognized, its...
solaci -
Ver más

SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

Transcatheter Deep Vein Arterialization in Critical Limb Ischemia Without Revascularization Options

Dr. Juan Manuel Pérez - 0
Chronic limb-threatening ischemia in patients without conventional revascularization options represents one of the most challenging scenarios within peripheral arterial disease, with 1-year major amputation...

Transcatheter Paravalvular Leak Closure: Mid-Term Outcomes and Prognostic Factors

Dr. Andrés Rodríguez - 0
Paravalvular leaks (PVL) are a frequent complication following surgical valve replacement, occurring in 5% to 18% of prosthetic valves. Incidence varies according to valve...

After a Major Bleeding Event in Atrial Fibrillation: When Should Left Atrial Appendage Closure Be Considered?

Dr. Juan Manuel Pérez - 0
Atrial fibrillation (AF) in patients who experience a major bleeding event represents a complex clinical scenario in which percutaneous left atrial appendage closure (LAAC)...

Noticias Institucionales

Fellow’s Corner 2026 – Submit Your Clinical Case

solaci - 0
Share your experience. Learn from experts. Grow as an interventional cardiologist. The Latin American Society of Interventional Cardiology (SOLACI) is relaunching this year the Fellow’s...

Watch Again: Cardiovascular Risk Factors in Women | SOLACI Technicians Webinar

solaci - 0
The webinar “Cardiovascular Risk Factors in Women,” held on January 27, 2026, via the Zoom platform, is now available for viewing on SOLACI’s YouTube...

Technical Training in Hemodynamics and Interventional Cardioangiology | SOLACI–CACI

solaci - 0
The SOLACI–CACI Technical Training in Hemodynamics and Interventional Cardioangiology is an academic program designed for the initial training and professional development of non-physician healthcare...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad